申请人:Schering Aktiengesellschaft
公开号:US04731365A1
公开(公告)日:1988-03-15
Compounds of formula I ##STR1## wherein n is 0 or 1, R.sup.1 is hydrogen or lower alkyl, R.sup.2 and R.sup.3 each independently is hydrogen, optionally substituted lower alkyl, acyl or aryl, or together with the nitrogen atom form a 5-6-member heterocycle, R.sup.4 is hydrogen, lower alkyl or lower alkoxyalkyl and X is COOR.sup.6, CO--NR.sup.7 R.sup.8, or an oxadiazolyl radical of the formula ##STR2## wherein R.sup.5 is H, lower alkyl or cycloalkyl, R.sup.6 is H or lower alkyl, R.sup.7 and R.sup.8 each independently is hydrogen, optionally substituted lower alkyl, acyl or aryl, or R.sup.7 and R.sup.8 together with the nitrogen atom can form a 5-6-member heterocycle, are valuable drugs, e.g., have psychotropic activity.
式I的化合物
##STR1##
其中n为0或1,R.sup.1为氢或较低烷基,R.sup.2和R.sup.3各自独立地为氢,可选择性地取代的较低烷基,酰基或芳基,或与氮原子一起形成5-6环杂环,R.sup.4为氢,较低烷基或较低烷氧基烷基,X为COOR.sup.6,CO--NR.sup.7 R.sup.8,或式的氧代二唑基
##STR2##
其中R.sup.5为H,较低烷基或环烷基,R.sup.6为H或较低烷基,R.sup.7和R.sup.8各自独立地为氢,可选择性地取代的较低烷基,酰基或芳基,或R.sup.7和R.sup.8与氮原子一起可以形成5-6环杂环,是有价值的药物,例如具有精神活性。